FDA Approves CLONAZEPAM — Advagen Pharma Ltd

Advagen Pharma Ltd obtained FDA approval on October 6, 2000, for its generic oral Clonazepam tablet under ANDA075468. The clearance is expected to bolster Advagen’s earnings potential by facilitating entry into the established anticonvulsant market with a cost-effective alternative.